Stocks making the biggest moves premarket: Chemours, Intel, BP and more
Early Morning Market Movers You Need to Know
Chemours – With an impressive 3% addition to its stock value, this chemical behemoth is turning heads after an upgrade from ‘buy’ to ‘neutral’ by UBS. The positive forecast is credited to a growing demand and advantageous pricing for refrigerants set to take off next year.
Nvidia – This silicon giant’s shares rose over 1% as KeyBanc set its sight higher for the chipmaker with a new price target of $180, representing a profit potential of over 40% based on Monday’s closing price. KeyBanc acknowledges strong H100 demand despite the impending Blackwell launch in the second half of 2024.
BP – Shares for this oil and gas powerhouse slipped by over 4% in US markets following the company’s warning of an impending impairment of up to $2 billion. The company also foresees weaker margins from its refining business.
Tempus AI – With a surge of almost 4%, the health care diagnostic firm has attracted Wall Street’s interest. Many banks initiated coverage of Tempus AI with ‘buy’ or ‘overweight’ ratings. The company, which uses AI to interpret medical tests, made its Nasdaq debut in June.
Intel – Witnessing a comeback this week, the chipmaker’s shares surged 2.7% in early trading. The week has seen the shares grow by approximately 6.1%.